A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

A supra-cellular model for coupling of bone resorption to formation during remodeling : lessons from two bone resorption inhibitors affecting bone formation differently. / Jensen, Pia Rosgaard; Andersen, Thomas Levin; Pennypacker, Brenda L; Duong, Le T; Engelholm, Lars H; Delaissé, Jean-Marie.

I: Biochemical and Biophysical Research Communications, Bind 443, Nr. 2, 10.01.2014, s. 694-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Jensen, PR, Andersen, TL, Pennypacker, BL, Duong, LT, Engelholm, LH & Delaissé, J-M 2014, 'A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently', Biochemical and Biophysical Research Communications, bind 443, nr. 2, s. 694-9. https://doi.org/10.1016/j.bbrc.2013.12.036

APA

Jensen, P. R., Andersen, T. L., Pennypacker, B. L., Duong, L. T., Engelholm, L. H., & Delaissé, J-M. (2014). A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently. Biochemical and Biophysical Research Communications, 443(2), 694-9. https://doi.org/10.1016/j.bbrc.2013.12.036

Vancouver

Jensen PR, Andersen TL, Pennypacker BL, Duong LT, Engelholm LH, Delaissé J-M. A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently. Biochemical and Biophysical Research Communications. 2014 jan. 10;443(2):694-9. https://doi.org/10.1016/j.bbrc.2013.12.036

Author

Jensen, Pia Rosgaard ; Andersen, Thomas Levin ; Pennypacker, Brenda L ; Duong, Le T ; Engelholm, Lars H ; Delaissé, Jean-Marie. / A supra-cellular model for coupling of bone resorption to formation during remodeling : lessons from two bone resorption inhibitors affecting bone formation differently. I: Biochemical and Biophysical Research Communications. 2014 ; Bind 443, Nr. 2. s. 694-9.

Bibtex

@article{4bc06e1d0ce949839d4fd07f920ea3d4,
title = "A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently",
abstract = "The bone matrix is maintained functional through the combined action of bone resorbing osteoclasts and bone forming osteoblasts, in so-called bone remodeling units. The coupling of these two activities is critical for securing bone replenishment and involves osteogenic factors released by the osteoclasts. However, the osteoclasts are separated from the mature bone forming osteoblasts in time and space. Therefore the target cell of these osteoclastic factors has remained unknown. Recent explorations of the physical microenvironment of osteoclasts revealed a cell layer lining the bone marrow and forming a canopy over the whole remodeling surface, spanning from the osteoclasts to the bone forming osteoblasts. Several observations show that these canopy cells are a source of osteoblast progenitors, and we hypothesized therefore that they are the likely cells targeted by the osteogenic factors of the osteoclasts. Here we provide evidence supporting this hypothesis, by comparing the osteoclast-canopy interface in response to two types of bone resorption inhibitors in rabbit lumbar vertebrae. The bisphosphonate alendronate, an inhibitor leading to low bone formation levels, reduces the extent of canopy coverage above osteoclasts. This effect is in accordance with its toxic action on periosteoclastic cells. In contrast, odanacatib, an inhibitor preserving bone formation, increases the extent of the osteoclast-canopy interface. Interestingly, these distinct effects correlate with how fast bone formation follows resorption during these respective treatments. Furthermore, canopy cells exhibit uPARAP/Endo180, a receptor able to bind the collagen made available by osteoclasts, and reported to mediate osteoblast recruitment. Overall these observations support a mechanism where the recruitment of bone forming osteoblasts from the canopy is induced by osteoclastic factors, thereby favoring initiation of bone formation. They lead to a model where the osteoclast-canopy interface is the physical site where coupling of bone resorption to bone formation occurs.",
keywords = "Animals, Bone Matrix, Bone Remodeling, Bone Resorption, Computer Simulation, Models, Biological, Osteoclasts, Rabbits, Spine",
author = "Jensen, {Pia Rosgaard} and Andersen, {Thomas Levin} and Pennypacker, {Brenda L} and Duong, {Le T} and Engelholm, {Lars H} and Jean-Marie Delaiss{\'e}",
note = "Copyright {\textcopyright} 2013 The Authors. Published by Elsevier Inc. All rights reserved.",
year = "2014",
month = jan,
day = "10",
doi = "10.1016/j.bbrc.2013.12.036",
language = "English",
volume = "443",
pages = "694--9",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - A supra-cellular model for coupling of bone resorption to formation during remodeling

T2 - lessons from two bone resorption inhibitors affecting bone formation differently

AU - Jensen, Pia Rosgaard

AU - Andersen, Thomas Levin

AU - Pennypacker, Brenda L

AU - Duong, Le T

AU - Engelholm, Lars H

AU - Delaissé, Jean-Marie

N1 - Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

PY - 2014/1/10

Y1 - 2014/1/10

N2 - The bone matrix is maintained functional through the combined action of bone resorbing osteoclasts and bone forming osteoblasts, in so-called bone remodeling units. The coupling of these two activities is critical for securing bone replenishment and involves osteogenic factors released by the osteoclasts. However, the osteoclasts are separated from the mature bone forming osteoblasts in time and space. Therefore the target cell of these osteoclastic factors has remained unknown. Recent explorations of the physical microenvironment of osteoclasts revealed a cell layer lining the bone marrow and forming a canopy over the whole remodeling surface, spanning from the osteoclasts to the bone forming osteoblasts. Several observations show that these canopy cells are a source of osteoblast progenitors, and we hypothesized therefore that they are the likely cells targeted by the osteogenic factors of the osteoclasts. Here we provide evidence supporting this hypothesis, by comparing the osteoclast-canopy interface in response to two types of bone resorption inhibitors in rabbit lumbar vertebrae. The bisphosphonate alendronate, an inhibitor leading to low bone formation levels, reduces the extent of canopy coverage above osteoclasts. This effect is in accordance with its toxic action on periosteoclastic cells. In contrast, odanacatib, an inhibitor preserving bone formation, increases the extent of the osteoclast-canopy interface. Interestingly, these distinct effects correlate with how fast bone formation follows resorption during these respective treatments. Furthermore, canopy cells exhibit uPARAP/Endo180, a receptor able to bind the collagen made available by osteoclasts, and reported to mediate osteoblast recruitment. Overall these observations support a mechanism where the recruitment of bone forming osteoblasts from the canopy is induced by osteoclastic factors, thereby favoring initiation of bone formation. They lead to a model where the osteoclast-canopy interface is the physical site where coupling of bone resorption to bone formation occurs.

AB - The bone matrix is maintained functional through the combined action of bone resorbing osteoclasts and bone forming osteoblasts, in so-called bone remodeling units. The coupling of these two activities is critical for securing bone replenishment and involves osteogenic factors released by the osteoclasts. However, the osteoclasts are separated from the mature bone forming osteoblasts in time and space. Therefore the target cell of these osteoclastic factors has remained unknown. Recent explorations of the physical microenvironment of osteoclasts revealed a cell layer lining the bone marrow and forming a canopy over the whole remodeling surface, spanning from the osteoclasts to the bone forming osteoblasts. Several observations show that these canopy cells are a source of osteoblast progenitors, and we hypothesized therefore that they are the likely cells targeted by the osteogenic factors of the osteoclasts. Here we provide evidence supporting this hypothesis, by comparing the osteoclast-canopy interface in response to two types of bone resorption inhibitors in rabbit lumbar vertebrae. The bisphosphonate alendronate, an inhibitor leading to low bone formation levels, reduces the extent of canopy coverage above osteoclasts. This effect is in accordance with its toxic action on periosteoclastic cells. In contrast, odanacatib, an inhibitor preserving bone formation, increases the extent of the osteoclast-canopy interface. Interestingly, these distinct effects correlate with how fast bone formation follows resorption during these respective treatments. Furthermore, canopy cells exhibit uPARAP/Endo180, a receptor able to bind the collagen made available by osteoclasts, and reported to mediate osteoblast recruitment. Overall these observations support a mechanism where the recruitment of bone forming osteoblasts from the canopy is induced by osteoclastic factors, thereby favoring initiation of bone formation. They lead to a model where the osteoclast-canopy interface is the physical site where coupling of bone resorption to bone formation occurs.

KW - Animals

KW - Bone Matrix

KW - Bone Remodeling

KW - Bone Resorption

KW - Computer Simulation

KW - Models, Biological

KW - Osteoclasts

KW - Rabbits

KW - Spine

U2 - 10.1016/j.bbrc.2013.12.036

DO - 10.1016/j.bbrc.2013.12.036

M3 - Journal article

C2 - 24333871

VL - 443

SP - 694

EP - 699

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -

ID: 108140480